Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,464 total articles

Asure Launches AsureCentral to Its Reseller Network, Extending Its Unified Platform to 85,000 More Employers

Asure Launches AsureCentral to Its Reseller Network, Extending Its Unified Platform to 85,000 More Employers

Asure Software has launched its AsureCentral platform to its reseller network, extending access from 30,000 direct employer clients to over 85,000 additional employer clients served by resellers. This integration enables resellers to manage payroll, HR, recruiting, time and attendance, and benefits solutions in a single platform, improving user exp…

Byrna Technologies Launches Media Campaign with iHeartMedia’s “The Bobby Bones Show” to Expand Mainstream Reach

Byrna Technologies Launches Media Campaign with iHeartMedia’s “The Bobby Bones Show” to Expand Mainstream Reach

Byrna Technologies Inc., a Nasdaq-listed personal defense company, has partnered with iHeartMedia's popular The Bobby Bones Show to launch a national media campaign. The campaign includes radio endorsements, podcasts, and digital placements aimed at expanding brand awareness and educating consumers on Byrna’s less-lethal personal safety devices. Th…

ZenaTech Reports 425% First Half and 316% Second-Quarter Year-Over-Year Revenue Growth as Drone as a Service Segment Continues to Scale

ZenaTech Reports 425% First Half and 316% Second-Quarter Year-Over-Year Revenue Growth as Drone as a Service Segment Continues to Scale

ZenaTech, Inc. reported a remarkable 316% year-over-year revenue increase in Q2 2026 and a 425% increase in the first half of 2026, primarily fueled by its Drone as a Service (DaaS) segment. The company expanded its geographic footprint through multiple acquisitions and newly opened offices internationally. Investments in AI-powered drone technolog…

Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation

Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation

Veracyte announced that a retrospective analysis of the phase III NRG/RTOG 0815 trial demonstrates their Decipher Prostate Genomic Classifier can predict which intermediate-risk prostate cancer patients benefit from adding short-term androgen deprivation therapy (ADT) to radiation. Patients with higher Decipher scores saw a significant reduction in…

Brunswick Corporation Announces Senior Leadership Appointments

Brunswick Corporation Announces Senior Leadership Appointments

Brunswick Corporation has announced the appointment of Will Sangster as EVP and President of Navico Group, Karly Yuds as SVP and President of Business Acceleration, and Marco Bracalente as Chief Technology Officer. These senior leadership changes follow the recent CEO and Board Chair transitions effective January 1, 2027. The appointments reflect B…

Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)

Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)

Tectonic Therapeutic announced favorable safety, tolerability, and pharmacokinetic results from its Phase 1a clinical trial of TX2100, a novel APJ receptor antagonist antibody for treating Hereditary Hemorrhagic Telangiectasia (HHT). The FDA granted Fast Track designation for TX2100 and cleared the IND application for a Phase 1b trial in HHT patien…

Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer

Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer

Corbus Pharmaceuticals has dosed the first patient in its TEMPO-1 registrational study evaluating CRB-701, a novel Nectin-4 targeted antibody drug conjugate, for treatment of second-line and beyond oropharyngeal squamous cell carcinoma (OPSCC). The Phase 3 randomized controlled trial aims to confirm the drug's efficacy and safety compared to curren…

TMC Announces Appointment of Liam Mallon, Former President of ExxonMobil Upstream, to its Board of Directors

TMC Announces Appointment of Liam Mallon, Former President of ExxonMobil Upstream, to its Board of Directors

The Metals Company has appointed Liam Mallon, ex-President of ExxonMobil Upstream, to its Board of Directors. Mallon's extensive experience in offshore energy projects and capital deployment will support TMC as it advances toward launching the world's first commercial-scale deep seabed mineral operations under U.S. regulatory frameworks. His leader…

Microchip Expands Single Pair Ethernet Portfolio with New 10BASE‑T1S Devices Enabling Scalable Edge Connectivity

Microchip Expands Single Pair Ethernet Portfolio with New 10BASE‑T1S Devices Enabling Scalable Edge Connectivity

Microchip Technology expands its Single Pair Ethernet portfolio with the launch of LAN8679 and LAN8680 10BASE-T1S PMD transceivers and the LAN8660X/1X/2X integrated endpoint family. These devices enable flexible, space-efficient, and reliable Ethernet connectivity for next-generation zonal architectures across automotive, industrial, robotics, aero…

One and One Green Technologies Reports First Half 2026 Results

One and One Green Technologies Reports First Half 2026 Results

One and One Green Technologies, Inc. announced financial results for the first half of 2026, reporting an 18.7% increase in revenue to $33.4 million and a 17.4% rise in net income to $4.5 million. Growth was fueled by a 39% increase in copper alloy ingot revenue due to stronger demand in Asia-Pacific and capacity reallocation, despite a temporary s…

Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting

Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting

Dianthus Therapeutics announced scheduled oral and poster presentations at the 2026 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting, showcasing encouraging Phase 2 and Phase 3 data for claseprubart, their investigational monoclonal antibody targeting autoimmune diseases such as generalized myasthenia grav…

Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron

Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron

Nasus Pharma has enrolled and dosed its first patient in the Phase 1 pharmacokinetic study of NS003, an intranasal powder formulation of ondansetron aimed at treating chemotherapy-induced and post-operative nausea and vomiting. Preclinical data showed NS003's pharmacokinetic profile comparable to IV ondansetron with a favorable safety profile. The …

SaverOne Awarded U.S. Patent for Automated Sensor Fusion Calibration and Maintenance: Strengthening its IP Protection as Fleet Deployments Scale

SaverOne Awarded U.S. Patent for Automated Sensor Fusion Calibration and Maintenance: Strengthening its IP Protection as Fleet Deployments Scale

SaverOne has been awarded a new U.S. patent for its advanced sensor fusion-based calibration and maintenance technology for its Phone Location Unit (PLU). This innovation allows the system to self-calibrate and maintain full operational accuracy over the vehicle's lifecycle, supporting efficient remote servicing at fleet scale. The patent strengthe…

Tokyo Lifestyle Co., Ltd. Strengthens Capital Structure Through Cash Investment and Debt-to-Equity Conversion

Tokyo Lifestyle Co., Ltd. Strengthens Capital Structure Through Cash Investment and Debt-to-Equity Conversion

Tokyo Lifestyle Co., Ltd. announced two key equity transactions approved by its board aimed at strengthening the company's capital structure. The Representative Director made a direct cash investment of approximately US$0.38 million, while an affiliated entity converted JPY510 million (approx. US$3.32 million) of outstanding shareholder-related deb…

Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD

Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD

Phathom Pharmaceuticals announced the initiation of a registrational Phase 3 study (pHalcon-NERD-302) to evaluate VOQUEZNA (vonoprazan) as an as-needed treatment for Non-Erosive GERD (NERD). Building on positive Phase 2 data, this study aims to assess the efficacy and safety of VOQUEZNA in providing rapid and sustained relief of heartburn episodes.…

NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease

NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease

NewAmsterdam Pharma has dosed the first participant in its Phase 2b SPINOZA clinical trial evaluating obicetrapib, a novel oral CETP inhibitor, in adults with biomarker evidence of preclinical Alzheimer's disease. The trial involves approximately 400 patients with specific ApoE genotypes and aims to assess changes in Alzheimer's disease biomarkers …

Provident Bank Survey: 7 in 10 Americans Are Rethinking Higher Education, and Nearly 1 in 3 Are Eyeing the Alternatives

Provident Bank Survey: 7 in 10 Americans Are Rethinking Higher Education, and Nearly 1 in 3 Are Eyeing the Alternatives

Provident Bank's 2026 Higher Education Survey shows nearly 70% of Americans are rethinking the financial value of traditional higher education amid rising costs, with increasing consideration for trade and technical schools as viable alternatives. The survey highlights gaps in education savings and a significant opportunity for banks to provide bet…

Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs

Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs

WW International, Inc. announces a strategic collaboration with Google Health Enterprise to enhance its weight management program through integration with Google's Fitbit Air wearable and AI-powered insights. The partnership aims to increase engagement and improve outcomes by offering personalized tracking of activity, sleep, and health signals to …